Pharmacoeconomic benefit of cisplatin and etoposide chemoregimen for metastatic non small cell lung cancer: An Indian study.

Chemotherapy regimens for metastatic nonsmall cell lung cancer: Generating good quality data is important before challenging evidence. Lung India (2016) 0.75

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med (2002) 24.87

PARAMOUNT: Final overall survival results of the phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer. J Clin Oncol (2013) 5.48

Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis. J Natl Cancer Inst (2007) 4.07

American Society of Clinical Oncology perspective: Raising the bar for clinical trials by defining clinically meaningful outcomes. J Clin Oncol (2014) 3.20

Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial. J Clin Oncol (1988) 2.91

Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial. J Clin Oncol (2000) 2.75

Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: the cancer and leukemia group B (study 9730). J Clin Oncol (2005) 2.48

Treatment of non-small cell lung cancer, stage IV: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 1.66

Economic cost analysis in cancer management and its relevance today. Indian J Cancer (2009) 1.49

A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC). Lung Cancer (2000) 1.45

Randomized trial of paclitaxel plus supportive care versus supportive care for patients with advanced non-small-cell lung cancer. J Natl Cancer Inst (2000) 1.33

Treatment of stage IV non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 1.33

Chemotherapy of advanced non-small-cell lung cancer: a comparison of three active regimens. A randomized trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.). Ann Oncol (1995) 1.11

Time for cooperation in health economics among the modelling community. Pharmacoeconomics (2010) 1.04

A randomized study comparing a high and a standard dose of cisplatin in combination with etoposide in the treatment of advanced non-small-cell lung carcinoma. J Clin Oncol (1986) 1.02

A case-control study of risk factors for lung cancer in Mumbai, India. Asian Pac J Cancer Prev (2011) 0.92

A randomized trial fo three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer Group. Cancer Chemother Pharmacol (1990) 0.92

The combination of etoposide and cisplatin in non-small-cell lung cancer (NSCLC). Ann Oncol (1999) 0.87

Chemotherapy for advanced lung cancer: a 5-year experience. Indian J Cancer (2008) 0.85

[Comparing cisplatin plus etoposide with combination of mitomycin, ifosfamide and cisplatin in advanced non-small cell lung cancer patients]. Tuberk Toraks (2006) 0.78

Cancer notification in India. South Asian J Cancer (2014) 0.96

A study of triple negative breast cancer at a tertiary cancer care center in southern India. Ann Med Health Sci Res (2014) 0.80

Locally advanced oral cavity squamous cell carcinoma: Barriers related to effective treatment. South Asian J Cancer (2015) 0.75

Outcomes, cost comparison, and patient satisfaction during long-term central venous access in cancer patients: Experience from a Tertiary Care Cancer Institute in South India. Indian J Med Paediatr Oncol (2017) 0.75

Bloodstream infections in febrile neutropenic patients at a tertiary cancer institute in South India: A timeline of clinical and microbial trends through the years. Indian J Med Paediatr Oncol (2016) 0.75

Plasma Epstein-Barr virus and Hepatitis B virus in non-Hodgkin lymphomas: Two lymphotropic, potentially oncogenic, latently occurring DNA viruses. Indian J Med Paediatr Oncol (2016) 0.75

Myelomatous pleural effusion: A rare case entity reported from a tertiary care cancer center in South India. Lung India (2017) 0.75

Current status of systemic therapy for recurrent and/or metastatic squamous cell carcinoma of the head and neck. Indian J Cancer (2017) 0.75

Induction chemotherapy in locally advanced T4b oral cavity squamous cell cancers: A regional cancer center experience. Indian J Cancer (1) 0.75

Plasma cell leukemia: Single institution experience. Indian J Cancer (2017) 0.75

Metastatic gastrointestinal stromal tumor: A regional cancer center experience of 44 cases. South Asian J Cancer (2017) 0.75

Multiple myeloma: Experience of an institute in limited resource setting. Indian J Cancer (1) 0.75

Plasmablastic lymphoma in immunocompetent and in immunocompromised patients: Experience at a regional cancer centre in India. South Asian J Cancer (2017) 0.75

Diffuse large B-cell lymphoma in elderly: Experience from a tertiary care oncology center in South India. South Asian J Cancer (2017) 0.75

Metastatic nonsmall cell lung cancer in South India: A regional demographic study. Indian J Cancer (1) 0.75

Efficacy and safety of first-line systemic chemotherapy with epirubicin, cisplatin plus 5-fluorouracil and docetaxel, cisplatin plus 5-fluorouracil regimens in locally advanced inoperable or metastatic gastric or gastroesophageal junction adenocarcinoma: A prospective phase II study from South India. Indian J Cancer (1) 0.75